Abstract
摘要
相似文献
1
Factor V.
Prog Hemost Thromb. 1976;3:109-43.
2
Determinants of the formation and activity of factor V-phospholipid complexes. II. Molecular properties of the complexes.凝血因子V-磷脂复合物形成及活性的决定因素。II. 复合物的分子特性。
Thromb Diath Haemorrh. 1975 Sep 30;34(1):271-84.
3
Studies of the conversion mechanism of prothrombin into thrombin.凝血酶原转化为凝血酶的转化机制研究。
Tohoku J Exp Med. 1974 Nov;114(3):215-25. doi: 10.1620/tjem.114.215.
4
Determinants of the formation and activity of factor V-phospholipid complexes. I. Influence of phospholipid structure.凝血因子V-磷脂复合物形成及活性的决定因素。I. 磷脂结构的影响。
Thromb Diath Haemorrh. 1975 Sep 30;34(1):256-70.
5
The intriguing world of prothrombin activators from snake venom.来自蛇毒的凝血酶原激活剂的奇妙世界。
Toxicon. 2005 Jun 15;45(8):1133-45. doi: 10.1016/j.toxicon.2005.02.019. Epub 2005 Apr 19.
6
7
Factor X.凝血因子X
Prog Hemost Thromb. 1984;7:55-109.
8
9
10
Relationship between factor V and activated factor X in the generation of prothrombinase.凝血酶原酶生成过程中因子V与活化因子X之间的关系。
Nature. 1967 May 27;214(5091):923-4. doi: 10.1038/214923a0.
引用本文的文献
1
Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.与血小板活化相关的膜变化。凝血酶诱导的分泌后肌动蛋白在血小板表面的暴露。
J Clin Invest. 1980 Jul;66(1):1-9. doi: 10.1172/JCI109821.
2
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.人凝血因子V缺乏的异质性。抗原阳性变体存在的证据。
J Clin Invest. 1983 Aug;72(2):493-503. doi: 10.1172/jci110997.
Zotero 插件